Serum lipids abnormalities and psoriasis

Indian Journal of Dermatology

Volumn 52, Issue 2, 2007, Pages 89-92

  Javidi, Zari ^a   Meibodi, Naser Tayyebi ^a   Nahidi, Yalda ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Lipid; Psoriasis; Serum

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHI SQUARE TEST; CHOLESTEROL BLOOD LEVEL; COMPUTER PROGRAM; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HYPERLIPIDEMIA; KRUSKAL WALLIS TEST; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PSORIASIS; RANK SUM TEST; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 34447341686     PISSN: 00195154     EISSN: None     Source Type: Journal    
DOI: 10.4103/0019-5154.33285     Document Type: Article

References (19)

1. Mallbris L, Larsson P, Bergquist S, Vingard E, Granath F, Stahle M. Psoriasis phenotype at disease onset: Clinical characterization of 400 adult cases. J Invest Dermatol 2005;124:499-504.
2. Pietrzak A, Lecewicz-Tourn B. Activity of serum Lipase [EC 3.1.1.3] and the diversity of serum lipid profile in Psoriasis. Med Sci Monit 2002;8:CR9-13.
3. Piskin S, Gurkok F, Ekuklu G, Senol M. Serum lipid levels in Psoriasis. Yonsei Med J 2003;44:24-6.
4. Henseler T, Christophors E. Disease concomitance in psoriasis. J Am Acad Dermatol 1995;32:982-6.
5. Mallbris L, Akre O, Granath F, Yin L, Lindelof B, Ekbom A, et al. Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients. Eur J Epidemiol 2004;19:225-30.
6. Seishima M, Seishima M, Mori S, Noma A. Serum lipid and apolipoprotein levels in patients with psoriasis. Br J Dermatol 1994;130:738-42.
7. Uyanik BS, Ari Z, Onur E, Gunduz K, Tanulku S, Durkan K. Serum lipids and apolipoproteins in patients with psoriasis. Clin Chem Lab Med 2002;40:65-8.
8. Mallbris L, Granath F, Hamsten A, Stahl M. Psoriasis is associated with lipid abnormalities at the onset of skin disease. J Am Acad Dermatol 2006;54:614-21.
9. Lea WA Jr, Cornish HH, Black WD. Studies on serum lipids protein and lipoproteins in psoriasis. J Invest Dermatol 1958;30:181-5.
10. Rocha-Preira P, Santos-Silva A, Rebelo I, Figueiredo A, Quintanilha A, Teixeira F. Dyslipdemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease. Clin Chim Acta 2001;303:33-90.
11. Pietrzak A, Lecewicz-Torun B, Jakimiuk A. Lipid and hormone profile in psoriatic females. Ann Univ Mariae Curie Sklodowska 2002;57:478-83.
12. Torkhovskaia TI, Fortinskaia ES, Ivanova LI, Nikitina NA, Zakharova TS, Kochetova MM, et al. Characteristics of the lipid transport system in psoriasis Vopr Med Khim 2002;48:297-303.
13. Takeda H, Okubo Y, Koga M, Aizawa K. Lipid analysis of peripheral blood monocytes in psoriatic patients using fourier-transform infrared microspectroscopy. J Dermatol 2001;28:303-11.
14. Gurkok F, Piskin S, Ekuklu G. Serum lipid and lipoprotein levels in psoriasis. Bull Leprosy 1999;30:105-11.
15. Fortinskaia ES, Torkhovskaia TI, Sharapova GI, Loginova TK, Kliuchnikova ZI, Khalilov EM. Features of distribution of free and esterified cholesterol in the epidermis, biological membranes and plasma lipoproteins in psoriasis. Klin Lab Diagn 1996;4:38-43.
16. Utas S, Pasaoglu H, Muhtaroglu S, Unver U, Utas C, Kelestimur F. Serum lipid profile in patients with psoriasis. T Klin J Dermatol 1995;5:18-29.
17. Seekin D, Tokgozoglu L, Akkaya S. Are Lipoprotein profile and lipoprotein (a) levels altered in men with psoriasis? J Am Acad Dermatol 1994;31:445-9.
18. Zheng L, Nukuna B, Brenn ML, Sun M, Goormastic M, Settle M, et al. Apolipoprotein A-I is a selective target for myeloperoxidase-catalysed oxidation and functional impairment in subjects with cardiovascular disease. J Clin Invest 2004;114:529-41.
19. Andreakos E, Foxwell B, Feldmann M. Is targeting Toll-like receptors and their signaling pathway a useful therapeutic approach to modulating cytokine-driven inflammation? Immunol Rev 2004;202:250-65.